Variant report
Variant | esv3410575 |
---|---|
Chromosome Location | chr8:10051667-10052174 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143683081 | chr8:10051672-10051673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537197579 | chr8:10051688-10051689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550383673 | chr8:10051703-10051704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200634480 | chr8:10051708-10051709 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10088463 | chr8:10051722-10051723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs555643461 | chr8:10051725-10051726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs543386020 | chr8:10051734-10051735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572363250 | chr8:10051740-10051741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1905634 | chr8:10051748-10051749 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs558177972 | chr8:10051750-10051751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577934012 | chr8:10051765-10051766 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs79627392 | chr8:10051774-10051775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563594602 | chr8:10051778-10051779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56281247 | chr8:10051792-10051793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186995864 | chr8:10051801-10051802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142932190 | chr8:10051825-10051826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559696878 | chr8:10051831-10051832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs151099712 | chr8:10051842-10051843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190282357 | chr8:10051848-10051849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141087812 | chr8:10051878-10051879 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1905633 | chr8:10051887-10051888 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs550666401 | chr8:10051903-10051904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs550628823 | chr8:10051909-10051910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146917063 | chr8:10051995-10051996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564402094 | chr8:10052012-10052013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549205671 | chr8:10052023-10052024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565930061 | chr8:10052048-10052049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147560079 | chr8:10052054-10052055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543512613 | chr8:10052076-10052077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182147146 | chr8:10052085-10052086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532411306 | chr8:10052097-10052098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565370802 | chr8:10052108-10052109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141969924 | chr8:10052128-10052129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537019636 | chr8:10052158-10052159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:10048200-10052200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:10050000-10057800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr8:10050000-10068000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr8:10050200-10053600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
5 | chr8:10050400-10054600 | Weak transcription | HMEC | breast |
6 | chr8:10050400-10054600 | Weak transcription | NHEK | skin |
7 | chr8:10050400-10055000 | Weak transcription | HSMMtube | muscle |
8 | chr8:10050400-10058000 | Weak transcription | Aorta | Aorta |
9 | chr8:10050600-10054800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr8:10050600-10055000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr8:10050800-10053800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr8:10051000-10052200 | Weak transcription | Fetal Brain Female | brain |
13 | chr8:10051600-10058400 | Enhancers | Fetal Brain Male | brain |